Cholesterol-Lowering Supplements: Investigation on 2 Deaths and 100 Hospitalizations

Investigation into Dietary Supplement Recall

An investigation has been launched into the recall of cholesterol-lowering supplements by Kobayashi Pharmaceutical.

Concerns Over Safety

• High: Two deaths and over 100 hospitalizations have led to concerns over the safety of the recalled supplements.
• High: Recall due to potential link to kidney disease.

Consumers advised to avoid the recalled supplements and seek medical advice if affected.